Mayne Pharma Group Limited

DB:HG6 Stock Report

Market Cap: €343.0m

Mayne Pharma Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:HG6 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Mar 25Buy€2,240,560UBS Asset Management AGCompany532,869€4.20
10 Mar 25Sell€2,133,024UBS Asset Management AGCompany507,229€4.21
07 Mar 25Buy€5,892,646UBS Asset Management AGCompany1,403,866€4.20
07 Mar 25Sell€5,609,653UBS Asset Management AGCompany1,336,160€4.20
04 Mar 25Sell€2,826,941MLC Investments LimitedCompany817,152€3.46
03 Mar 25Buy€223,127Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany51,919€4.30
03 Mar 25Sell€334,802Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany78,003€4.29
03 Mar 25Sell€373,723IOOF Investment Management LimitedCompany96,709€3.98
01 Mar 25Buy€48,944IOOF Investment Management LimitedCompany16,992€3.17
28 Feb 25Sell€27,635,699Viburnum Funds Pty Ltd.Company6,428,268€4.31
24 Feb 25Buy€342,218First Sentier Investors (Australia) IM LtdCompany103,984€4.37
19 Feb 25Buy€1,676,762MLC Investments LimitedCompany583,838€2.87
14 Jan 25Buy€5,772Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany2,093€2.76
10 Jan 25Buy€45,280OnePath Funds Management LimitedCompany16,055€2.82
27 Nov 24Buy€340,458The Vanguard Group, Inc.Company130,113€3.00
17 Oct 24Buy€4,427,330MLC Investments LimitedCompany1,579,910€2.80
15 Oct 24Sell€626,312IOOF Investment Management LimitedCompany150,414€4.40
10 Oct 24Sell€955,624MLC Investments LimitedCompany347,961€2.75
30 Aug 24Buy€228,872IOOF Investment Management LimitedCompany90,540€2.53
25 Jun 24Sell€80,062OnePath Funds Management LimitedCompany28,667€2.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HG6?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,055,7668.68%
Private Companies7,227,9778.9%
Institutions29,301,48936.1%
General Public37,660,59546.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 53.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.47%
UBS Asset Management AG
6,066,575€25.6m221%no data
6.51%
Bruce Mathieson
5,292,066€22.3m0%no data
6.38%
Bmgbj Myx Pty Ltd
5,183,477€21.9m0%no data
5.92%
Goldman Sachs Group, Investment Banking and Securities Investments
4,810,445€20.3m0%0.01%
5.14%
Morgan Stanley, Investment Banking and Brokerage Investments
4,180,019€17.6m0%no data
5.11%
The Vanguard Group, Inc.
4,148,229€17.5m1.27%no data
3.99%
MLC Investments Limited
3,239,407€13.7m-6.72%4.87%
2.43%
Dimensional Fund Advisors LP
1,972,517€8.3m-0.56%no data
2.09%
Credit Suisse Funds AG
1,701,480€7.2m0%0.11%
1.17%
First Sentier Investors (Australia) IM Ltd
950,443€4.0m-66.8%0.01%
0.98%
IVL Group Pty Ltd
800,000€3.4m0%no data
0.64%
Roger Corbett
522,028€2.2m0%no data
0.63%
Y S Chains Pty Ltd
510,000€2.2m0%no data
0.63%
Zhang Yunsong
510,000€2.2m0%no data
0.56%
IOOF Investment Management Limited
458,815€1.9m-14.8%0.1%
0.52%
Kon Tzimokas
420,000€1.8m0%no data
0.51%
Norges Bank Investment Management
413,308€1.7m0%no data
0.47%
Birbal Investments Pty Ltd
380,000€1.6m0%no data
0.44%
Wal Assets Pty Ltd
354,500€1.5m0%no data
0.42%
Blackstone Inc.
341,518€1.4m0%0.01%
0.39%
Blackstone Alternative Asset Management L.P.
314,685€1.3m0%0.29%
0.33%
OnePath Funds Management Limited
264,161€1.1m6.47%0.86%
0.18%
Charles Schwab Investment Management, Inc.
147,199€621.5k-0.96%no data
0.094%
BlackRock, Inc.
76,447€322.8k-2.69%no data
0.092%
Eaton Vance Management
75,156€317.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 07:30
End of Day Share Price 2025/03/17 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mayne Pharma Group Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William DunlopBofA Global Research
Martyn JacobsCanaccord Genuity
Elyse ShapiroCanaccord Genuity